About Cookies

We want you to enjoy your visit to our website. That's why we use cookies to enhance your experience. By staying on our website you agree to our use of cookies.

Prostate tests 'would cut deaths'

Screening for prostate cancer is controversial because the initial diagnostic test patients have, to measure blood levels of the biomarker prostate specific antigen, is unreliable.

Screening for prostate cancer is controversial because the initial diagnostic test patients have, to measure blood levels of the biomarker prostate specific antigen, is unreliable.

Promoted Stories

Comments are closed on this article.

Keep in touch with local news

Sign up for email alerts

Most read stories

  • 1